AP
ZBH icon

Atwood & Palmer’s Zimmer Biomet ZBH Stock Holding History

Atwood & Palmer’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30
Closed -$3.17K – 485
2024
Q4 		$3.17K Hold
30
– – ﹤0.01% 396
2024
Q3 		$3.24K Buy
+30
New +$3.27K ﹤0.01% 389
2016
Q2 		– Sell
-371
Closed -$38K – 318
2016
Q1 		$38K Sell
371
-31
-8% -$3K 0.01% 191
2015
Q4 		$40K Hold
402
– – 0.01% 218
2015
Q3 		$37K Hold
402
– – 0.01% 212
2015
Q2 		$43K Hold
402
– – 0.01% 193
2015
Q1 		$46K Sell
402
-41
-9% -$4.68K 0.01% 190
2014
Q4 		$49K Sell
443
-669
-60% -$70.5K 0.01% 198
2014
Q3 		$109K Buy
1,112
+741
+200% +$72.9K 0.02% 164
2014
Q2 		$37K Buy
+371
New +$36.2K 0.01% 203

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Atwood & Palmer's ZBH Position: Q1 2025 in Review

Atwood & Palmer sold out of Zimmer Biomet (ZBH) in Q1 2025, closing a stake of 30 shares — an estimated $3.17K sold.

Atwood & Palmer first reported a position in ZBH in Q2 2014 and held it in 10 quarters. The position peaked at $109K in Q3 2014. 1,000 funds tracked by Wall St. Rank hold ZBH as of Q1 2025.

  • Atwood & Palmer reported no remaining Zimmer Biomet position as of Q1 2025 after selling out during the quarter.
  • Atwood & Palmer sold 30 Zimmer Biomet shares in Q1 2025, an estimated $3.17K.
  • Atwood & Palmer first reported a position in Zimmer Biomet in Q2 2014 and held it in 10 quarters.
  • Atwood & Palmer's Zimmer Biomet position peaked at $109K in Q3 2014.
  • 1,000 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2025.

Based on Atwood & Palmer's 13F filing for Q1 2025, filed 15 Apr 2025.